drugset / Trial / NCT00633126

Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

NCT00633126

Phase 1 Completed 9 enrolled Forest Laboratories
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects

Timeline

Start
2008-03
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline Other / unclassified 8 mg/kg Other
Subject Ceftaroline Other / unclassified 600 mg Other

Indications